CSIMarket Company Name, Ticker, Customers, else..


Prometheus Biosciences Inc   (NASDAQ: RXDX)
Other Ticker:  
 

Prometheus Biosciences Inc

RXDX's Fundamental analysis



Prometheus Biosciences Inc 's sales fell by -71.8 % in the third quarter of 2023 from the same quarter a year ago. Ranking at No. 4009

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.34 %

Prometheus Biosciences Inc net loss increased from $-32 millions, to $-41 millions in third quarter of 2023,

• More on RXDX's Growth


Prometheus Biosciences Inc
realized a net loss in trailing twelve months.

Prometheus Biosciences Inc realized cash reduction of $ -3.14 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2375.08.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.17.


• More on RXDX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 27,937
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 14.70

Prometheus Biosciences Inc
realized net loss in trailing twelve months.

Prometheus Biosciences Inc realized cash outflow of $ -3.14per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2375.08.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.17.

Prometheus Biosciences Inc Price to Book Ratio is at 13.6 lower than Industry Avg. of 111.43. and higher than S&P 500 Avg. of 0.02

• More on RXDX's Valuation

•  Market Capitalization (Millions $) 9,488
•  Shares Outstanding (Millions) 47
•  Employees 143
•  Revenues (TTM) (Millions $) 4
•  Net Income (TTM) (Millions $) -151
•  Cash Flow (TTM) (Millions $) -149
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 27,937
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 14.70

•  Market Capitalization (Millions $) 9,488
•  Shares Outstanding (Millions) 47
•  Employees 143
•  Revenues (TTM) (Millions $) 4
•  Net Income (TTM) (Millions $) -151
•  Cash Flow (TTM) (Millions $) -149
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 37.56
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.09
•  Asset Turnover Ratio (TTM) 0.01
•  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.